Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
The UAS7 tracker quantifies daily hive counts and itch severity on a 0–3 scale over seven days, producing a weekly score that lets doctors objectively assess urticaria control and adjust therapies.
There are several factors to consider, including setup, scoring details, interpretation ranges, tracking tips, tech tools, and when to seek care; see below for complete guidance and next steps.
Chronic urticaria (hives) can significantly impact your quality of life. The Urticaria Activity Score over seven days (UAS7) is a simple, evidence-based tool doctors use to monitor disease activity and guide treatment decisions. By tracking your daily symptoms with a UAS7 tracker, you and your healthcare provider can make informed adjustments to medications, lifestyle measures, and other therapies.
The UAS7 tracker quantifies two key features of urticaria every day for a week:
Each feature is scored on a 0–3 scale daily and summed over seven days. Total scores range from 0 (no disease activity) to 42 (severe activity).
• Provides an objective measure of symptom severity
• Helps your doctor tailor and adjust treatments
• Tracks response to new or modified therapies
• Improves communication between you and your healthcare team
• Empowers you to participate actively in managing your condition
• 0 points: No hives
• 1 point: Mild (<20 wheals/24 hours)
• 2 points: Moderate (20–50 wheals/24 hours)
• 3 points: Severe (>50 wheals/24 hours or large confluent areas of wheals)
• 0 points: None
• 1 point: Mild (present but not annoying or troublesome)
• 2 points: Moderate (troublesome but does not interfere with daily activities or sleep)
• 3 points: Severe (interferes with daily activities or sleep)
Daily UAS = (Hives score) + (Itch score)
Range: 0–6
Record this number in your tracker for each of the seven days.
At the end of Day 7, add your daily scores:
UAS7 = Sum of daily UAS scores (Day 1 → Day 7)
Range: 0–42
Write the total in the "Weekly Total" box on your tracker.
Doctors commonly use these ranges to assess urticaria activity:
• 0–6 points: Well controlled
• 7–15 points: Mild activity
• 16–27 points: Moderate activity
• 28–42 points: Severe activity
These categories help determine if you need to continue, step up, or step down your therapy.
Baseline Assessment
• Obtain an initial UAS7 before starting or changing treatment.
• Classify disease severity to guide first-line therapies.
Monitoring Treatment Response
• Repeat UAS7 approximately every 2–4 weeks after treatment changes.
• Identify early responders versus non-responders.
• Adjust antihistamines, add omalizumab, or explore alternative therapies as needed.
Long‐Term Follow-Up
• Use UAS7 to track disease control over months or years.
• Decide on tapering or discontinuation of medications when scores consistently fall in the well-controlled range.
Patient Education and Engagement
• Review the tracker together during appointments.
• Empower patients to understand their scores and participate in shared decision-making.
Many patients find digital apps or simple spreadsheet templates more convenient than paper. Some platforms allow you to:
Always choose tools that comply with data privacy standards.
While UAS7 is invaluable for tracking chronic urticaria, it does not replace professional medical assessment. If you're experiencing new or worsening symptoms and need guidance before your next appointment, you can get immediate support through a Medically approved LLM Symptom Checker Chat Bot to help you understand your symptoms better. Seek emergency care immediately if you experience:
If any of these occur, seek emergency care immediately, and then speak to your doctor about your UAS7 scores and next steps.
| Day | Hives (0–3) | Itch (0–3) | Daily UAS (0–6) |
|---|---|---|---|
| Day 1 | |||
| Day 2 | |||
| Day 3 | |||
| Day 4 | |||
| Day 5 | |||
| Day 6 | |||
| Day 7 | |||
| Total | 0–42 |
Q: Can I start treatment based on a single-day score?
A: One-day scores can guide urgent decisions but are less reliable than a full UAS7. Always aim for a seven-day assessment.
Q: What if I miss a day?
A: Do your best to recall the worst 24-hour period. If you cannot estimate reliably, note the gap and discuss it with your doctor.
Q: How often should I repeat UAS7?
A: After initiating or changing treatment, repeat every 2–4 weeks. Once stable, track monthly or per your doctor's recommendation.
The urticaria activity score UAS7 tracker is a powerful, doctor-recommended tool that transforms subjective symptoms into clear data. Proper use of the UAS7 empowers you and your healthcare provider to:
Remember, if you experience any life-threatening or serious symptoms, seek emergency medical care immediately and speak to a doctor about your UAS7 results and overall management plan.
(References)
* Zuberbier T, Aberer W, Asero A, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018 May;73(5):e1-e39.
* Zuberbier T, Aberer W, Asero A, Bindslev-Jensen C, Canonica GW, et al. EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria 2017: update for the UAS7. Allergy. 2017 May;72(5):713-722.
* Kolkhir P, Andreae C, Weller K, Metz M, Maurer M. The use of UAS7 in clinical practice for chronic urticaria. J Dtsch Dermatol Ges. 2021 Mar;19(3):328-336.
* Weller K, Magerl M, Maurer M. The Urticaria Activity Score (UAS7): A Review of the Validity, Reliability, and Responsiveness in Chronic Urticaria. J Investig Allergol Clin Immunol. 2015;25(5):344-9.
* Weller K, Zuberbier T, Maurer M. Chronic Urticaria: The Importance of Patient-Reported Outcomes. J Allergy Clin Immunol Pract. 2015 Nov-Dec;3(6):839-47.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.